SCHEMBL21654544

SCHEMBL21654544

Cc1ncc(-c2ccc(-c3cc(F)c(C)c(F)c3)c(C)c2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 3/20 0.42
▸ PDE3A Q14432 3/20 0.42
▸ FEN1 P39748 3/20 0.39
▸ ALOX5AP P20292 2/20 0.39
▸ VRK1 Q99986 1/20 0.38
▸ ABL1 P00519 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ GRIN2B Q13224 4/20 0.34
▸ DGAT1 O75907 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ HSD17B1 P14061 1/20 0.34
▸ HSD17B2 P37059 1/20 0.34
▸ HSD17B14 Q9BPX1 1/20 0.34
▸ RPS6KA3 P51812 2/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22198980 0.79 GRIN2B (0.48) GRIN2BCYP2C19RPS6KA3DAPK3NTRK1
SCHEMBL13310783 0.79 AKR1C3 (0.48) PDE3BPDE3AFEN1ALOX5APAKR1C3
SCHEMBL13310775 0.78 NISCH (0.44) PDE3BPDE3AVRK1ABL1AKR1C3
SCHEMBL13310767 0.77 PDE3B (0.48) PDE3BPDE3AFEN1ALOX5APRPS6KA3
SCHEMBL91804 0.76 AKR1C3 (0.41) PDE3BPDE3AFEN1ALOX5APAKR1C3
SCHEMBL15243549 0.75 PDE3B (0.44) PDE3BPDE3AABL1GRIN2BGRIN1
SCHEMBL26392530 0.75 RPS6KA3 (0.39) PDE3BPDE3AFEN1ALOX5APAKR1C3
SCHEMBL13703910 0.71 AKR1C3 (0.49) PDE3BPDE3AFEN1ALOX5APAKR1C3
SCHEMBL27325025 0.69 PTGS2 (0.43) CYP3A4HSD17B1HSD17B2DAPK3NTRK1
SCHEMBL17149180 0.68 ALDH1A1 (0.36) PDE3BPDE3AVRK1GRIN2BCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544365-B2 Nematic liquid crystal composition DIC CORPORATION (JP) 2020-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544365-B2 Nematic liquid crystal composition DOCK5, CDKL5, NCS1 PDE3B 2006/4885PDE3A 1040/4885FEN1 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback